The Medical Technology activities of ZEISS are bundled under the umbrella of the TecDAX-listed company Carl Zeiss Meditec AG. This corporate website provides information on the performance of Carl Zeiss Meditec AG with dedicated investor relations services and services for media professionals.
With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world in major markets. The company can also exploit the Carl Zeiss group`s powerful global distribution network.
Be informed about the performance, key facts and the shareholder structure.
Revenue, EBIT and earnings per share show positive development
Carl Zeiss Meditec AG consolidates its ophthalmology activities in a single Strategic Business Unit; James V. Mazzo will head the new ophthalmology division.
Thomas Simmerer will leave the Management Board of Carl Zeiss Meditec AG effective September 30, 2016
Earnings per share and EBIT increase/forecast for fiscal year specified in more detail